HEMOGLOBIN-S AND HEMOGLOBIN-C - REFERENCE VALUES FOR GLYCOHEMOGLOBIN IN HETEROZYGOUS, DOUBLE-HETEROZYGOUS AND HOMOZYGOUS SUBJECTS, AS ESTABLISHED BY 13 METHODS

被引:21
作者
WEYKAMP, CW [1 ]
MARTINA, WV [1 ]
VANDERDIJS, FPL [1 ]
PENDERS, TJ [1 ]
VANDERSLIK, W [1 ]
MUSKIET, FAJ [1 ]
机构
[1] UNIV GRONINGEN HOSP, CENT LAB CLIN CHEM, 9700 RB GRONINGEN, NETHERLANDS
关键词
GLYCATED HEMOGLOBIN VARIANTS; HETEROZYGOUS AND HOMOZYGOUS SICKLE CELL ANEMIA; SICKLE CELL HBSC DISEASE; HETEROZYGOUS AND HOMOZYGOUS HEMOGLOBIN C; ALPHA-THALASSEMIA;
D O I
10.1016/0009-8981(94)90200-3
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Glycohemoglobin (gly-Hb) reference ranges of non-diabetic adults with HbAA (n = 17), HbAS (n = 37), HbAC (n = 22), HbSC (n = 8), HbSS (n = 6) and HbCC (n = 3) were determined by 13 methods, based on affinity chromatography, HPLC, electrophoresis and immunoassay, Gly-Hb of subjects with HbAS and HbAC can be measured without major difficulties by most methods. Some give rise to absolute gly-Hb differences greater than or equal to 1% compared with subjects with HbAA. Measurement of HbA(lc)/total Hb cannot be recommended. Some HPLC and immunoassay methods cannot measure gly-Hb in subjects with HbSC, HbSS and HbCC, whereas others may suffer from interference. Most methods showed low gly-Hb, reflecting increased erythrocyte turnover. Use of special reference ranges requires previous knowledge of the condition (affinity chromatography and immunoassay) or separation of gly-Hb and its precursor Hb (HPLC and electrophoresis). Interpretation is, however, not recommended because of the numerous factors that determine erythrocyte turnover.
引用
收藏
页码:161 / 171
页数:11
相关论文
共 19 条
[1]   DETERMINANTS OF HEMOGLOBIN LEVEL IN SICKLE CELL HEMOGLOBIN-C DISEASE [J].
BANNERMAN, RM ;
SERJEANT, B ;
SEAKINS, M ;
ENGLAND, JM ;
SERJEANT, GR .
BRITISH JOURNAL OF HAEMATOLOGY, 1979, 43 (01) :49-56
[2]  
BEUTLER E, 1983, HEMATOLOGY, P583
[3]   BIOSYNTHESIS OF HUMAN HEMOGLOBIN A1C - SLOW GLYCOSYLATION OF HEMOGLOBIN INVIVO [J].
BUNN, HF ;
HANEY, DN ;
KAMIN, S ;
GABBAY, KH ;
GALLOP, PM .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (06) :1652-1659
[4]  
BUNN HF, 1987, BLOOD, V69, P1
[5]  
DEDMON RE, 1959, AM J CLIN PATHOL, V31, P487
[6]  
FRASER CG, 1990, CLIN CHEM, V36, P1625
[7]  
Goldstein DE, 1982, DIABETES S3, V31, P70
[8]  
LADENSON JH, 1985, CLIN CHEM, V31, P1060
[9]   A COMPARISON OF ANALYTICAL GOALS FOR HEMOGLOBIN A1C ASSAYS DERIVED USING DIFFERENT STRATEGIES [J].
LARSEN, ML ;
FRASER, CG ;
PETERSEN, PH .
ANNALS OF CLINICAL BIOCHEMISTRY, 1991, 28 :272-278
[10]  
MARTINA WV, 1993, CLIN CHEM, V39, P2259